1. Ahmed AF, Mahmoud ME. Prevalence of hypertension in Saudi Arabia. Saudi Med J 1992; 13: 548-551.
2. El-Hazmi MAF, Al-Swailem A, Wasry AS, Sulimani R. Prevalence of diabetes mellitus in Saudi Arabia. Saudi Med J 1995; 6: 294-299.
3. Suematsu C, Hayashi T, Fujji S, Endo G, Tsumura K, Okada K et al. Impaired fasting glucose and the risk of hypertension in Japanese men between the 1980s and the 1990s: the Osaka Health Survey. Diabetes Care 1999; 22: 228-229.
4. Hayashi T, Tsumura K, Suematsu C, Endo G, Fujji S, Okada K. High normal blood pressure, hypertension, and the risk of type 2 diabetes in Japanese men. Diabetes Care 1999; 22: 1683-1687.
5. Manson JE, Nathan DM, Krolewski AS, Stampfer M, Willet WC, Hennekens CH. JA prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992; 268: 63-67.
6. Stolk RP, Van splunder IP, Schouten JS, Witterman JC, Hofman A, Grobbee DE. High blood pressure and the incidence of non-insulin dependent diabetes mellitus: findings in a 11.5 year follow up study in the Netherlands. Eur J Epidemiol 1993; 9: 134-139.
7. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992; 19: 403-418.
8. Weidmann P, Boehlen LM, De Courten M. Pathogenesis and treatment of hypertension associated with diabetes mellitus. Am Heart J 1993; 125: 1498-1513.
9. The National High Blood Pressure Education Program Working Group: National high blood pressure education program working group report on hypertension in diabetes. Hypertension 1994; 23: 145-158.
10. The Hypertension in Diabetes Study Group. Hypertension in Diabetes Study (HDS): 1. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications; II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens 1993; 11: 309-319.
11. Wokoma FS. Hypertension in non-insulin dependent diabetic Nigerians: a comparative analysis of normotensive and hypertensive subgroups. Diabetes International 1999; 9: 57-58.
12. Diabetes mellitus: report of a WHO Study Group. World Health Organ Tech Rep Ser 1985; 727: 1-113.
13. Rapp JP. Genetics of experimental and human hypertension. In: Genest J, Kuchel O, Hamet P, Cantin M, editors. Hypertension, physiopathology and treatment. 2nd ed. New York: McGraw Hill Book Company; 1983. p. 582-598.
14. Albrink MJ, Meigs JW. The relationship between serum triglyceride and skinfold thickness in obese subjects. Ann N Y Acad Sci 1965; 131: 673-683.
15. Davidson P, Albrink MJ. Abnormal plasma insulin response with high plasma triglycerides independent of clinical diabetes or obesity. J Clin Invest 1966; 45: 1000-1005.
16. Bagdade JD, Bierman EL, Porte D Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and non diabetic subjects. J Clin Invest 1967; 46: 1549-1557.
17. Reaven GM, Lener RL, Stern MP, Farquhar JW. Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 1967; 46: 1756-1767.
18. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.
19. Haffner SM. The insulin resistance syndrome revisited. Diabetes Care 1996; 19: 275-277.
20. Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Eng J Med 1996; 334: 952-957.
21. Bierman Ell. Atherogenesis in diabetes. Arterioscler Thromb 1992; 12: 647-656.
22. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38) BMJ 1998; 317: 703-713.
23. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfedt D, Julius S et al for the HOT Study Group. Effects of intensive blood pressure lowering and low dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 755-762.